Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-08-16
2011-08-16
Cheu, Jacob (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C436S518000
Reexamination Certificate
active
07998687
ABSTRACT:
The invention relates to the analysis and identification of genes that are modulated in transplant rejection. This alteration of gene expression provides a molecular signature to accurately detect transplant rejection.
REFERENCES:
patent: 2003/0104371 (2003-06-01), Strom et al.
patent: 99/15700 (1999-04-01), None
patent: 03/062467 (2003-07-01), None
patent: 2004/018710 (2004-03-01), None
patent: 2004/074815 (2004-09-01), None
Racusen L.C. et al., “The banff 97 working classification of renal allograft pathology”, Kidney International, vol. 55, pp. 713-723, (1999).
Nankivell B.J. et al., “The natural history of chronic allograft nephropathy”, The New England Journal of Medicine, vol. 349, No. 24, pp. 2326-2333, (2003).
Cheu Jacob
Fischer Leslie
Novartis AG
Novartis Pharma GmbH
LandOfFree
Biomarkers for chronic transplant dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers for chronic transplant dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for chronic transplant dysfunction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2765568